4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001650664-24-000103
CEO sold 1,555 shares at $3.42 ($5,325)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
O'Neill Gilmore Neil · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-04 | Sale : show line 1 in the form 10b5-1 | −1,555 | $3.42 | $5,325 | 313,724 | D |
| Open-market sales · 1,555 sh · avg $3.42 · $5,325 | ||||||
Loading xslF345X05/wk-form4_1725653893.xml…